Ipilimumab/NivolumabLack of efficacy: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2039卷 / 1期

关键词：

D O I：

10.1007/s40278-024-72719-x

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：282 / 282

相关论文

共 50 条

[41] NivolumabLack of efficacy: case report
Reactions Weekly, 2025, 2056 (1) : 429 - 429
[42] NivolumabLack of efficacy: case report
Reactions Weekly, 2025, 2048 (1) : 336 - 336
[43] Ipilimumab/melphalan/nivolumabLack of efficacy and immune therapy-related hepatitis: case report
Reactions Weekly, 2022, 1897 (1) : 217 - 217
[44] Imatinib/nivolumabLack of efficacy: case report
Reactions Weekly, 2023, 1974 (1) : 177 - 177
[45] Infliximab/ipilimumab/nivolumabLack of efficacy and colitis: 2 case reports
Reactions Weekly, 2022, 1931 (1) : 314 - 314
[46] Binimetinib/Encorafenib/Ipilimumab/nivolumabLack of efficacy: 2 case reports
Reactions Weekly, 2025, 2050 (1) : 117 - 117
[47] Ipilimumab/nivolumabLack of efficacy and autoimmune colitis: 2 case reports
Reactions Weekly, 2024, 2035 (1) : 252 - 252
[48] Catequentinib/nivolumabLack of efficacy: case report
Reactions Weekly, 2022, 1910 (1) : 129 - 129
[49] Fluorouracil/NivolumabLack of efficacy: case report
Reactions Weekly, 2025, 2056 (1) : 208 - 208
[50] Lomustine/nivolumabLack of efficacy: case report
Reactions Weekly, 2022, 1918 (1) : 295 - 295

← 1 2 3 4 5 →